Myconostica CE marks MycAssay tests on new platforms
This article was originally published in Clinica
UK diagnostics specialist Myconostica has CE marked its MycAssay Aspergillus and Pnuemocystis tests for use on Roche's Lightcycler 2.0 and Stratagene's Mx3000 system. The products had previously been CE marked for use with Cepheid's Smartcycler and Applied Biosystems' ABI 7500. Together, these devices are the four most common real-time PCR machines in clinical microbiology and mycology labs, Manchester-based Myconostica claims. The first test detects Aspergillus species, one of the most common causes of fungal pneumonia. The second detects Pnuemocystis jirovecii; this fungus can cause pneumonia in immunocompromised people. Both tests can product results in three hours when used with the firm's MycXtra fungal DNA extraction system, using lower respiratory tract samples.